Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore · Delayed Price · Currency is SGD · Price in USD 3.570
+0.080 (2.29%)
At close: Feb 27, 2026
66.82% (1Y)
| Market Cap | 5.43B +44.0% |
| Revenue (ttm) | 972.89M -33.3% |
| Net Income | 648.69M +283.7% |
| EPS | 0.84 +285.0% |
| Shares Out | n/a |
| PE Ratio | 8.36 |
| Forward PE | n/a |
| Dividend | 0.67 (18.63%) |
| Ex-Dividend Date | Jan 30, 2026 |
| Volume | 56,700 |
| Average Volume | 272,975 |
| Open | 3.490 |
| Previous Close | 3.490 |
| Day's Range | 3.490 - 3.590 |
| 52-Week Range | 1.990 - 3.750 |
| Beta | n/a |
| RSI | 59.80 |
| Earnings Date | Mar 31, 2026 |